Cannabis Penny Stocks: Cannvas Medtech and Benchmark Botanics

Penny Stocks

We’re looking at Benchmark Botanics and Cannvas Medtech cannabis penny stocks today. Both these stocks closed down yesterday, but that won’t stop these two powering on!

Cannabis Penny Stocks: Cannvas Medtech

Cannvas MedTech Inc. (CSE:MTEC) is a technology company focused on harnessing cannabis data for the better.

It is doing so via its state-of-the-art website called, which is a verified database detailing all-things marijuana related. Here, casual users, medical users, and anyone else in between can receive purely unbiased education about marijuana.

Now, Cannvas is taking its education to the next level. Operating under its newly-formed Cannvas Cannabis Acquisitions brand, the company will install a network of education kiosks across retail areas in Canada.

The plan is to improve accessibility to free and unbiased education about the potential benefits of medical and adult-use cannabis.

Enter Your E-mail Address To Subscribe

* indicates required

According to the company “We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.”

Today, Cannvas stock is down 6.45% and is currently selling for $0.44 CAD. However, data is big business, so the potential in this cannabis penny stock is big. Education in this sector can only grow as this young industry develops.

Cannabis Penny Stocks: Benchmark Botanics

Also in the red today is Benchmark Botanics (CSE:BBT). Benchmark stocks are selling for $0.50 at the time of writing. But don’t let this low price fool you. Benchmark has been busy and is set for an exciting 2019.

First of all, the company appointed a new Chief Executive Officer—Mr. William Ying. Ying takes over from Mr. Johnston Zhang, Co-founder and a company Director who has stepped down, saying the following about his tenure as CEO:

“It has been a great honor to serve as the CEO of Benchmark since its inception. I take great pride in our team’s collective accomplishments and the exceptional progress we have made in such a short period of time.”

Also this month, the company secured an important agreement with 1139000 B.C. Ltd to develop greenhouse operations on four acres in Pitt Meadows, British Columbia.

>> Cannabis Penny Stocks to Watch: Auxly Cannabis Group

Benchmark—through its wholly-owned subsidiary Potancials Green Growers Inc.—will now apply for an ACMPR license for this acreage. Once this license is procured, Benchmark will earn a 25% interest in 1139000, which remains the owner of the land. Once Benchmark has developed the land to commercial stages, it will then be able to increase ownership to 51% of 1139000.

Further, the company has expressed its excitement for the legalization of recreational marijuana. The company has full confidence in its recent license agreement with The Bulldog. Using The Bulldog trademarks, it is aiming to build an engaging and successful brand of cannabis products for the adult-use market.

So while the cannabis penny stocks market looks a little flat these days, don’t worry, it isn’t keeping any of these companies down. 

Featured Image: Depositphotos/© dotcom